Home › Research › Brain tissue and pathology
To reveal and acknowledge an iatrogenic cerebral amyloid angiopathy: a vascular neurologist and neurosurgeon collaborative perspective
Senta Frol, Bruno Splavski. Frontiers in Neurology, 2025-06-13
Topic: Amyloid, tau and blood-test diagnosis
Plain-language summary
It is often associated with recurrent ICH, seizures, and cognitive impairment.It is thought to arise from prior exposure to cadaveric materials, such as lyophilized dural grafts, used in neurosurgical procedures, and shares pathophysiological mechanisms with prion diseases, where Aβ deposition is mediated by the transmission of misfolded proteins (6).Diagnosing iCAA requires a detailed medical history to identify potential exposure to sources of Aβ, with clinical symptoms frequently manifesting decades after the initial surgery, typically with a latency period of 30 to 40 years.A critical analysis of current research reveals that iCAA has shifted from a theoretical concern to a documented reality with significant implications for both patient care and medical ethics.By understanding iCAA's prion-like transmission mechanism and reassessing surgical practices, the medical community can take proactive steps to reduce the incidence of this devastating, but preventable condition.In light of these findings, this opinion paper argues for an increased clinical awareness of iCAA as a potential diagnosis in younger patients presenting with atypical ICH.The emergence of iCAA underscores the unintended long-term effects of neurosurgical practices once thought safe. This demands a paradigm shift in the neurological and neurosurgical approach, where diagnostic workups should include a history of neurosurgical interventions involving cadaveric dural grafts and incorporate advanced imaging and biomarker analysis specific to Aβ accumulation.The iCAA clues include the onset of symptoms earlier in life (<50 years), a history of neurosurgical treatment using cadaveric material, clinical and neuroradiologic features associated with CAA, evidence of Aß brain tissue, as well as the exclusion of CAA genetic causes ( 4). However, early-onset forms, though uncommon, are being increasingly recognized and may result from genetic or iatrogenic causes that warrant specific and focused investigation and management (7). Notably, patients with iCAA are significantly younger than those with sporadic CAA, which is often related to the historical use of lyophilized dural transplants during childhood (8,9). These progressive neurodegenerative disorders result from prions-misfolded proteins that are the smallest infectious agents, even smaller than viruses, and lack nucleic acids (DNA or RNA) in their structure (16). Prions are highly resistant to conventional disinfection methods, posing sign
What this study adds
Evidence grade: Moderate
This opinion paper describes iatrogenic cerebral amyloid angiopathy as a documented condition that may arise from prior exposure to cadaveric materials such as lyophilized dural grafts used in neurosurgery, often appearing 30 to 40 years later. It argues for increased clinical awareness and for reassessing surgical practices to reduce this preventable condition.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Frol, S., & Splavski, B. (2025). To reveal and acknowledge an iatrogenic cerebral amyloid angiopathy: a vascular neurologist and neurosurgeon collaborative perspective. Frontiers in Neurology. https://doi.org/10.3389/fneur.2025.1527417
Vancouver
Frol S, Splavski B. To reveal and acknowledge an iatrogenic cerebral amyloid angiopathy: a vascular neurologist and neurosurgeon collaborative perspective. Frontiers in Neurology. 2025. doi:10.3389/fneur.2025.1527417. PMID: 40584521.
BibTeX
@article{frol2025-40584521,
author = {Frol, Senta and Splavski, Bruno},
title = {{To reveal and acknowledge an iatrogenic cerebral amyloid angiopathy: a vascular neurologist and neurosurgeon collaborative perspective}},
journal = {Frontiers in Neurology},
year = {2025},
doi = {10.3389/fneur.2025.1527417},
pmid = {40584521},
url = {https://doi.org/10.3389/fneur.2025.1527417}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- It is often associated with recurrent ICH, seizures, and cognitive impairment.It is thought to arise from prior exposure to cadaveric materials, such as lyophilized dural grafts, used in neurosurgical procedures, and shares pathophysiological mechanisms with prion diseases, where Aβ deposition is me
- This demands a paradigm shift in the neurological and neurosurgical approach, where diagnostic workups should include a history of neurosurgical interventions involving cadaveric dural grafts and incorporate advanced imaging and biomarker analysis specific to Aβ accumulation.The iCAA clues include the onset of symptoms earlier in life (<50 years), a history of neurosurgical treatment using cadaveric material, clinical and neuroradiologic features associated with CAA, evidence of Aß brain tissue, as well as the exclusion of CAA genetic causes ( 4).
- However, early-onset forms, though uncommon, are being increasingly recognized and may result from genetic or iatrogenic causes that warrant specific and focused investigation and management (7).
- Notably, patients with iCAA are significantly younger than those with sporadic CAA, which is often related to the historical use of lyophilized dural transplants during childhood (8,9).
- These progressive neurodegenerative disorders result from prions-misfolded proteins that are the smallest infectious agents, even smaller than viruses, and lack nucleic acids (DNA or RNA) in their structure (16).
Why it matters
This opinion paper describes iatrogenic cerebral amyloid angiopathy as a documented condition that may arise from prior exposure to cadaveric materials such as lyophilized dural grafts used in neurosurgery, often appearing 30 to 40 years later. It argues for increased clinical awareness and for reassessing surgical practices to reduce this preventable condition.
Study details
- Evidence strengthModerate
How this study scored 36/100
Published in a peer-reviewed journal. Scored zero for study design, sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Frontiers in Neurology) |
| Journal's citation record | 2 / 4 | Frontiers in Neurology: journal h-index 162 (OpenAlex, 2026-10-29) |
| Study design | 0 / 12 | No study design recorded — scores zero, not guessed (not stated in the record — scored 0) |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 4 / 5 | 2025 — within 3 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 1 / 7 | Cited 2 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.7 citations a year over 3 year(s) since 2025 |
| Impact for its field and year | 2 / 6 | Cited 1.1× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 2 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 1 / 4 | Last-listed author Bruno Splavski: h-index 17 (OpenAlex, whole career) |
| Institution's track record | 0 / 3 | University of Ljubljana: institution h-index 544 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 40584521) |
| Free to read | 2 / 2 | Free to read |
| Total | 36 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
- DOI: 10.3389/fneur.2025.1527417
- PubMed: 40584521
- Original source →
- Free full text: Frontiers in Neurology →
Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Brain tissue and pathology from nearby years
Also tagged “small”
900 studies in the library carry the topic tag “small”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 900 tagged studies.